Correlation Between Eupraxia Pharmaceuticals and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Zenas BioPharma, Common, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Zenas BioPharma,.
Diversification Opportunities for Eupraxia Pharmaceuticals and Zenas BioPharma,
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eupraxia and Zenas is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Zenas BioPharma,
Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 1.03 times more return on investment than Zenas BioPharma,. However, Eupraxia Pharmaceuticals is 1.03 times more volatile than Zenas BioPharma, Common. It trades about 0.1 of its potential returns per unit of risk. Zenas BioPharma, Common is currently generating about -0.32 per unit of risk. If you would invest 250.00 in Eupraxia Pharmaceuticals Common on September 23, 2024 and sell it today you would earn a total of 49.00 from holding Eupraxia Pharmaceuticals Common or generate 19.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Eupraxia Pharmaceuticals Commo vs. Zenas BioPharma, Common
Performance |
Timeline |
Eupraxia Pharmaceuticals |
Zenas BioPharma, Common |
Eupraxia Pharmaceuticals and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eupraxia Pharmaceuticals and Zenas BioPharma,
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.Eupraxia Pharmaceuticals vs. Sea | Eupraxia Pharmaceuticals vs. Olympic Steel | Eupraxia Pharmaceuticals vs. Nok Airlines Public | Eupraxia Pharmaceuticals vs. American Airlines Group |
Zenas BioPharma, vs. enGene Holdings Common | Zenas BioPharma, vs. FT Vest Equity | Zenas BioPharma, vs. Zillow Group Class | Zenas BioPharma, vs. Northern Lights |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |